MR
About
Matthew Roden is based out of Princeton, New Jersey, and is the President, Chief Executive Officer, and board of Directors of Aktis Oncology. Matthew Roden previously worked at NextPoint Therapeutics as Board of Directors. Matthew Roden attended the Georgetown University.
Position in the VCSift Database
- • 76 investors hold the President and Chief Executive Officer role in VCSift. Matthew Roden is one of them.
- • 125 investors are based in Princeton, New Jersey, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Princeton, US
Contact Information
linkedin.com/in/••••••••
Find more investors like Matthew
Search Investors